Sangamo Therapeutics (NASDAQ:SGMO) Hits New 12-Month High After Analyst Upgrade
Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Free Report)’s share price hit a new 52-week high during trading on Wednesday after HC Wainwright raised their price target on the stock from $5.00 to $10.00. HC Wainwright currently has a buy rating on the stock. Sangamo Therapeutics traded as high as $2.45 and last traded at $2.44, […]
6 Nov 15:48 · The Cerbat Gem